Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4851
CEVA Inc
CEVA
$1.08B
| $35K | ﹤0.01% |
1,600
-600
| -27% | -$12.4K |
|
|
CHN
4852
DELISTED
China Fund
CHN
| $35K | ﹤0.01% |
2,496
| – | – |
|
4853
PUT
State Street SPDR S&P China ETF
GXC
$482M
| $35K | ﹤0.01% |
500
| – | – |
|
4854
CALL
Hovnanian Enterprises
HOV
$807M
| $35K | ﹤0.01% |
1,396
-840
| -38% | -$31.8K |
|
4855
Insmed
INSM
$28.6B
| $35K | ﹤0.01% |
2,920
+2,028
| +227% | +$26.7K |
|
4856
PUT
KBR
KBR
$4.8B
| $35K | ﹤0.01% |
2,300
-41,400
| -95% | -$585K |
|
4857
Bank OZK
OZK
$5.61B
| $35K | ﹤0.01% |
862
-3,975
| -82% | -$167K |
|
4858
Insulet
PODD
$9.79B
| $35K | ﹤0.01% |
1,075
-29,218
| -96% | -$917K |
|
4859
CALL
Pool Corp
POOL
$7.5B
| $35K | ﹤0.01% |
+400
| New | +$32.2K |
|
4860
Stock Yards Bancorp
SYBT
$2.6B
| $35K | ﹤0.01% |
+1,367
| New | +$34.2K |
|
4861
PUT
Upbound Group
UPBD
$1.16B
| $35K | ﹤0.01% |
2,300
-2,900
| -56% | -$38.7K |
|
|
HNP
4862
CALL
DELISTED
Huaneng Power Intl, Inc.
HNP
| $35K | ﹤0.01% |
+1,000
| New | +$32.9K |
|
|
ARNA
4863
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $35K | ﹤0.01% |
3,530
-12,940
| -79% | -$207K |
|
|
CRR
4864
CALL
DELISTED
Carbo Ceramics Inc.
CRR
| $35K | ﹤0.01% |
2,500
-5,100
| -67% | -$88K |
|
|
AAV
4865
DELISTED
Advantage Oil & Gas Ltd
AAV
| $35K | ﹤0.01% |
6,900
-10,700
| -61% | -$55.7K |
|
|
CEB
4866
DELISTED
CEB Inc.
CEB
| $35K | ﹤0.01% |
550
-7,034
| -93% | -$403K |
|
4867
CALL
Aegon
AEG
$14.1B
| $34K | ﹤0.01% |
9,321
+7,930
| +570% | +$30.7K |
|
4868
CALL
Apogee Enterprises
APOG
$908M
| $34K | ﹤0.01% |
+800
| New | +$31.7K |
|
4869
CALL
Popular Inc
BPOP
$11.1B
| $34K | ﹤0.01% |
1,200
-1,400
| -54% | -$36.7K |
|
4870
CALL
BorgWarner
BWA
$13.9B
| $34K | ﹤0.01% |
1,022
-1,364
| -57% | -$40.5K |
|
4871
CALL
Crown Holdings
CCK
$13.1B
| $34K | ﹤0.01% |
700
-2,300
| -77% | -$108K |
|
4872
CALL
Enbridge
ENB
$112B
| $34K | ﹤0.01% |
900
-3,400
| -79% | -$116K |
|
4873
CALL
EQT Corp
EQT
$32.3B
| $34K | ﹤0.01% |
919
-30,494
| -97% | -$976K |
|
4874
Hexcel
HXL
$7.82B
| $34K | ﹤0.01% |
801
-1,095
| -58% | -$46K |
|
|
IMOS
4875
PUT
ChipMOS TECHNOLOGIES
IMOS
$1.83B
| $34K | ﹤0.01% |
1,815
-8,349
| -82% | -$160K |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.